- Investing Ideas
- /
- Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
2
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
2 companies
Duopharma Biotech Berhad
Market Cap: RM 1.2b
An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.
New
DPHARMA
RM 1.28
7D
-3.0%
1Y
13.3%
Y.S.P. Southeast Asia Holding Berhad
Market Cap: RM 305.0m
Engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally.
YSPSAH
RM 2.15
7D
0.9%
1Y
-18.3%